Free Trial
NASDAQ:GRAL

GRAIL (GRAL) Stock Price, News & Analysis

GRAIL logo
$32.42 +0.81 (+2.56%)
Closing price 09/3/2025 04:00 PM Eastern
Extended Trading
$32.49 +0.07 (+0.23%)
As of 06:14 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About GRAIL Stock (NASDAQ:GRAL)

Key Stats

Today's Range
$31.75
$32.97
50-Day Range
$31.42
$51.42
52-Week Range
$12.33
$63.99
Volume
591,705 shs
Average Volume
743,995 shs
Market Capitalization
$1.17 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$31.50
Consensus Rating
Hold

Company Overview

GRAIL Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
27th Percentile Overall Score

GRAL MarketRank™: 

GRAIL scored higher than 27% of companies evaluated by MarketBeat, and ranked 851st out of 938 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    GRAIL has received a consensus rating of Hold. The company's average rating score is 2.25, and is based on 1 buy rating, 3 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    GRAIL has received no research coverage in the past 90 days.

  • Read more about GRAIL's stock forecast and price target.
  • Earnings Growth

    Earnings for GRAIL are expected to grow in the coming year, from ($15.15) to ($12.95) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of GRAIL is -2.47, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of GRAIL is -2.47, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    GRAIL has a P/B Ratio of 0.50. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about GRAIL's valuation and earnings.
  • Percentage of Shares Shorted

    15.23% of the float of GRAIL has been sold short.
  • Short Interest Ratio / Days to Cover

    GRAIL has a short interest ratio ("days to cover") of 3.9, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in GRAIL has recently decreased by 5.41%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    GRAIL does not currently pay a dividend.

  • Dividend Growth

    GRAIL does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    15.23% of the float of GRAIL has been sold short.
  • Short Interest Ratio / Days to Cover

    GRAIL has a short interest ratio ("days to cover") of 3.9, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in GRAIL has recently decreased by 5.41%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    GRAIL has a news sentiment score of 1.17. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.70 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 9 news articles for GRAIL this week, compared to 7 articles on an average week.
  • Search Interest

    Only 3 people have searched for GRAL on MarketBeat in the last 30 days. This is a decrease of -40% compared to the previous 30 days.
  • MarketBeat Follows

    Only 2 people have added GRAIL to their MarketBeat watchlist in the last 30 days. This is a decrease of -67% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, GRAIL insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $17,780,266.00 in company stock.

  • Read more about GRAIL's insider trading history.
Receive GRAL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GRAIL and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

GRAL Stock News Headlines

Free: The Crypto Summit That Could Change Your Life
27 industry leaders share urgent market intel (free access)... For a very limited time, you can claim your spot for FREE.tc pixel
See More Headlines

GRAL Stock Analysis - Frequently Asked Questions

GRAIL's stock was trading at $17.85 at the beginning of 2025. Since then, GRAL shares have increased by 81.6% and is now trading at $32.42.

GRAIL, Inc. (NASDAQ:GRAL) issued its quarterly earnings results on Tuesday, August, 12th. The company reported ($3.18) EPS for the quarter, missing the consensus estimate of ($3.14) by $0.04. The business had revenue of $35.54 million for the quarter, compared to analysts' expectations of $37.57 million. GRAIL had a negative trailing twelve-month return on equity of 16.64% and a negative net margin of 329.86%.
Read the conference call transcript
.

GRAIL's top institutional investors include Primecap Management Co. CA (5.71%), AQR Capital Management LLC (3.70%), State Street Corp (3.47%) and Geode Capital Management LLC (2.11%). Insiders that own company stock include Chun R Ding, Robert P Ragusa, Joshua J Ofman and Aaron Freidin.
View institutional ownership trends
.

Shares of GRAL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that GRAIL investors own include NVIDIA (NVDA), Tesla (TSLA), Advanced Micro Devices (AMD), Meta Platforms (META), Netflix (NFLX), JPMorgan Chase & Co. (JPM) and Visa (V).

Company Calendar

Last Earnings
8/12/2025
Today
9/03/2025
Next Earnings (Estimated)
11/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Healthcare
Current Symbol
NASDAQ:GRAL
Previous Symbol
NASDAQ:GRAL
CIK
1699031
Web
N/A
Fax
N/A
Employees
1,360
Year Founded
N/A

Price Target and Rating

High Price Target
$43.00
Low Price Target
$20.00
Potential Upside/Downside
-2.8%
Consensus Rating
Hold
Rating Score (0-4)
2.25
Research Coverage
4 Analysts

Profitability

EPS (Trailing Twelve Months)
($13.11)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$2.03 billion
Net Margins
-329.86%
Pretax Margin
-445.82%
Return on Equity
-16.64%
Return on Assets
-14.02%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
9.23
Quick Ratio
9.23

Sales & Book Value

Annual Sales
$125.60 million
Price / Sales
9.31
Cash Flow
$28.44 per share
Price / Cash Flow
1.14
Book Value
$64.21 per share
Price / Book
0.50

Miscellaneous

Outstanding Shares
36,050,000
Free Float
N/A
Market Cap
$1.17 billion
Optionable
Optionable
Beta
3.18

Social Links

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:GRAL) was last updated on 9/4/2025 by MarketBeat.com Staff
From Our Partners